Powerful Medical Receives €40 Million Non-Dilutive Grant to Accelerate Early Diagnosis of Cardiovascular Diseases with AI
Brussels, Belgium – July 28th, 2025 – Powerful Medical, a leader in AI-driven cardiovascular diagnostics, has been selected to receive over €40 million (USD $46 million) in non-dilutive grant funding through the European Commission’s IPCEI Tech4cure project initiative. This grant represents one of the largest EU contributions in a healthcare technology company to date and will be used to accelerate global adoption and clinical validation of PMcardio® – the world’s first AI-powered platform for rapid and accurate cardiovascular diagnostics.
Powerful Medical leads the battle against cardiovascular diseases, the number one cause of death worldwide, with heart attacks accounting for the majority of these fatalities. The company’s flagship solution, PMcardio, is a certified medical device that enables clinicians to detect acute heart attacks and 48 other cardiac abnormalities like heart failure and arrhythmias directly at the first point of contact – with twice the sensitivity and up to 3 hours earlier than current methods. With the ability to analyze a standard 12-lead ECG image within seconds and compare it against millions of past patient records, the device delivers immediate, evidence-based diagnostics, addressing a critical gap in today’s clinical practice.
